Global Snoring Control Devices Market 2017-2021

SKU ID :TNV-10359487 | Published Date: 13-Mar-2017 | No. of pages: 70
Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • MADs • TSDs • Nasal devices • Chin straps • EPAP • Others PART 07: Market segmentation by end-user • Hospitals • Sleep labs • Home-care settings PART 08: Geographical segmentation • Snoring control devices market in Americas • Snoring control devices market in EMEA • Snoring control devices market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 11: Market trends • Use of 3D printing technology in the production of snoring control devices • Growing focus toward online promotional and marketing strategies • Integration of mobile devices with home healthcare systems PART 12: Vendor landscape • Competitive landscape analysis PART 13: Key vendor analysis • GlaxoSmithKline • MPowrx Health and Wellness Products • ResMed • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits Exhibit 01: Market overview: Global snoring control devices Exhibit 02: Global snoring control devices market 2016-2021 ($ billions) Exhibit 03: Five forces analysis Exhibit 04: Global snoring control devices market segmentation by product 2016 Exhibit 05: Global MADs market 2016-2021: Market overview Exhibit 06: Key product offerings: MADs Exhibit 07: Global MADs market 2016-2021 ($ billions) Exhibit 08: Global TSDs market 2016-2021: Market overview Exhibit 09: Key product offerings: TSDs Exhibit 10: Global TSDs market 2016-2021 ($ billions) Exhibit 11: Global nasal devices market 2016-2021: Market overview Exhibit 12: Key product offerings: Nasal devices Exhibit 13: Global nasal devices market 2016-2021 ($ billions) Exhibit 14: Global chin straps market 2016-2021: Market overview Exhibit 15: Key product offerings: Chin straps Exhibit 16: Global chin straps market 2016-2021 ($ billions) Exhibit 17: Global EPAP market 2016-2021: Market overview Exhibit 18: Key product offerings: EPAP Exhibit 19: Global EPAP market 2016-2021 ($ billions) Exhibit 20: Global other snoring control devices market 2016-2021 ($ billions) Exhibit 21: Global snoring control devices market by end-user 2016 (%) Exhibit 22: Global snoring control devices market by geographical segmentation 2016 (%) Exhibit 23: Market overview: Snoring control devices market in Americas Exhibit 24: Snoring control devices market in Americas 2016-2021 ($ billions) Exhibit 25: Market overview: Snoring control devices market in EMEA Exhibit 26: Snoring control devices market in EMEA 2016-2021 ($ billions) Exhibit 27: Market overview: Snoring control devices market in APAC Exhibit 28: Snoring control devices market in APAC 2016-2021 ($ billions) Exhibit 29: Impact of drivers Exhibit 30: Cost of surgical procedures Exhibit 31: Impact of challenges Exhibit 32: Competitive structure analysis of global snoring control devices market 2016 Exhibit 33: Competitive landscape analysis of global snoring control devices market 2016 Exhibit 34: Strategic factors determining success for leading companies in global snoring control devices market Exhibit 35: GlaxoSmithKline: Key highlights Exhibit 36: GlaxoSmithKline: Strength assessment Exhibit 37: GlaxoSmithKline: Strategy assessment Exhibit 38: GlaxoSmithKline: Opportunity assessment Exhibit 39: MPowrx Health and Wellness Products: Key highlights Exhibit 40: MPowrx Health and Wellness Products: Strength assessment Exhibit 41: MPowrx Health and Wellness Products: Strategy assessment Exhibit 42: MPowrx Health and Wellness Products: Opportunity assessment Exhibit 43: ResMed: Key highlights Exhibit 44: ResMed: Strength assessment Exhibit 45: ResMed: Strategy assessment Exhibit 46: ResMed: Opportunity assessment Exhibit 47: Other prominent vendors
GlaxoSmithKline, MPowrx Health and Wellness Products, ResMed, AirSnore, Apnea Sciences, MEDiTAS, Sleeping Well, SleepTight Mouthpiece, SNOREDOC, SnoreMeds, TheraSnore, VitalSleep, and ZYPPAH.
  • PRICE
  • $2500
    $4000

Our Clients